Life Sciences Tools and Services
Company Overview of Absorption Systems, LP
Absorption Systems, LP operates as a preclinical contract research organization. The company assists pharmaceutical, biotechnology, and medical device companies in identifying and overcoming absorption, distribution, metabolism, excretion, and toxicity barriers in the development of drugs, biologics, and medical devices. It offers preclinical services comprising predesigned and customizable assays and studies, which include lead optimization, NDA-enabling and IND-enabling, and bioanalysis services. The company also provides preclinical formulation profiling and characterization of biologics focusing on polypeptides, recombinant proteins, monoclonal antibodies, protein conjugates, nucleic aci...
436 Creamery Way
Exton, PA 19341
Founded in 1996
Key Executives for Absorption Systems, LP
Co-Founder, Chief Executive Officer and President
Co-Founder and Chief Scientific Officer
Vice President of Scientific and Corporate Communications
Compensation as of Fiscal Year 2014.
Absorption Systems, LP Key Developments
Absorption Systems Announces License Agreement with Pfizer Inc
Jul 15 14
Absorption Systems announced a license agreement with Pfizer Inc., in which Pfizer will in-license Absorption Systems' BCRP-MDCK cells. This cell line is stably transfected with the human ABCG2 gene, which codes for a protein known as BCRP (breast cancer resistance protein). This proprietary human BCRP assay system is designed to enable the testing of new drug candidates for interactions with the BCRP protein, which is involved in drug clearance, blood-brain barrier penetration, resistance of tumors to anticancer drugs, and drug-drug interactions. As a result of BCRP interactions, compounds that show promising efficacy in vitro may be inaccessible to the organ of interest during clinical trials.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries